Metrics
6 Record Views
- Title
- P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA
- Creators
- Ewa Lech-Marańda - Instytut Hematologii i TransfuzjologiAgata Szymańska - Gdańsk Medical UniversityJan Zaucha - Gdańsk Medical UniversityGautam Borthakur - The University of Texas MD Anderson Cancer CenterScott Solomon - Northside HospitalTerrence Bradley - Sylvester Comprehensive Cancer CenterElie Mouhayar - The University of Texas MD Anderson Cancer CenterNoemi Angelosanto - Ryvu Therapeutics, Krakow, PolandHendrik Nogai - Ryvu Therapeutics, Krakow, PolandKrzysztof Brzozka - Ryvu Therapeutics, Krakow, PolandTomasz Rzymski - Ryvu Therapeutics, Krakow, PolandPeter Littlewood - Ryvu Therapeutics, Krakow, PolandKamil Kus - Ryvu Therapeutics, Krakow, PolandRenata Dudziak - Ryvu Therapeutics, Krakow, PolandAxel Glasmacher - University Clinic Bonn, Internal Medicine III, Bonn, GermanyHoward Burris - Sarah CannonCamille Abboud - Washington University in St. Louis
- Publication Details
- HemaSphere, Vol.7, p.e27994b8
- Academic Unit
- UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031923021002976